title: Interferon-alpha may restore sensitivity to tyrosine-kinase inhibitors in Philadelphia chromosome positive acute lymphoblastic leukaemia with F317L mutation.
authors: Leonardo
authors: L
authors: Potenza
authors: Francesco
authors: F
authors: Volzone
authors: Giovanni
authors: G
authors: Riva
authors: Simona
authors: S
authors: Soverini
authors: Silvia
authors: S
authors: Martinelli
authors: Ilaria
authors: I
authors: Iacobucci
authors: Alessandra
authors: A
authors: Gnani
authors: Patrizia
authors: P
authors: Barozzi
authors: Fabio
authors: F
authors: Forghieri
authors: Monica
authors: M
authors: Morselli
authors: Eleonora
authors: E
authors: Zanetti
authors: Monica
authors: M
authors: Maccaferri
authors: Michele
authors: M
authors: Baccarani
authors: Giovanni
authors: G
authors: Martinelli
authors: Giuseppe
authors: G
authors: Torelli
authors: Mario
authors: M
authors: Luppi
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D001549:Benzamides; D005260:Female; D016044:Fusion Proteins, bcr-abl / Q000235:genetics; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy* / Q000235:genetics; D008875:Middle Aged; D009154:Mutation / Q000235:genetics*; D010879:Piperazines / Q000627:therapeutic use; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*; D011743:Pyrimidines / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D000068877:Imatinib Mesylate; D011505:Protein-Tyrosine Kinases; D016044:Fusion Proteins, bcr-abl